Frontiers in cell and developmental biology · 2026
MAML-residual transformer for few-shot prediction of targeted therapy response in NSCLC.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lu Hua-Jun, Ren Guo-Chao, Chen Dao-Gui, Lv Guo-Xiao, Ying Ting, Qi Hui-Xin, Hua Jia-Dong, Wang Chao-Qun
Аннотация
INTRODUCTION: Non-small cell lung cancer (NSCLC) exhibits high heterogeneity, and the scarcity of annotated imaging data limits the robustness and generalization capability of conventional deep learning approaches, particularly in few-shot scenarios. Therefore, developing accurate and generalizable prediction models under limited sample conditions remains a critical challenge for precision oncology.
METHODS: In this study, we proposed a Model-Agnostic Meta-Learning_RT (MAML_RT) framework for predicting targeted therapy response in NSCLC. The framework integrates model-agnostic meta-learning with residual transformers. Multi-task meta-training was employed to learn highly generalizable parameter initializations, enabling rapid adaptation to new cohorts with limited labeled samples. Meanwhile, the multi-head self-attention mechanism of the residual transformer was utilized to model global correlations among radiomics features and capture long-range dependencies between diverse tumor phenotypic characteristics.
RESULTS: In a cohort of 300 patients, MAML_RT achieved an accuracy of 0.91 and an area under the receiver operating characteristic curve (AUC) of 0.93 for predicting targeted therapy efficacy. Under an extremely small-sample scenario (n = 50), the model maintained an AUC of 0.76, significantly outperforming the comparison models. Furthermore, on an independent external validation cohort, MAML_RT achieved an AUC of 0.85 and an accuracy of 0.88, demonstrating its cross-center generalization capability.
DISCUSSION: The proposed MAML_RT framework provides an effective solution for targeted therapy response prediction in NSCLC under limited labeled data conditions. By integrating meta-learning with residual transformer-based feature modeling, this approach improves model adaptability and generalization, offering potential support for clinical decision-making and individualized treatment stratification.
METHODS: In this study, we proposed a Model-Agnostic Meta-Learning_RT (MAML_RT) framework for predicting targeted therapy response in NSCLC. The framework integrates model-agnostic meta-learning with residual transformers. Multi-task meta-training was employed to learn highly generalizable parameter initializations, enabling rapid adaptation to new cohorts with limited labeled samples. Meanwhile, the multi-head self-attention mechanism of the residual transformer was utilized to model global correlations among radiomics features and capture long-range dependencies between diverse tumor phenotypic characteristics.
RESULTS: In a cohort of 300 patients, MAML_RT achieved an accuracy of 0.91 and an area under the receiver operating characteristic curve (AUC) of 0.93 for predicting targeted therapy efficacy. Under an extremely small-sample scenario (n = 50), the model maintained an AUC of 0.76, significantly outperforming the comparison models. Furthermore, on an independent external validation cohort, MAML_RT achieved an AUC of 0.85 and an accuracy of 0.88, demonstrating its cross-center generalization capability.
DISCUSSION: The proposed MAML_RT framework provides an effective solution for targeted therapy response prediction in NSCLC under limited labeled data conditions. By integrating meta-learning with residual transformer-based feature modeling, this approach improves model adaptability and generalization, offering potential support for clinical decision-making and individualized treatment stratification.